Abstract C44: Endometrial carcinoma recurrence in black and white women in the NRG Oncology/Gynecologic Oncology Group 210 trial
Ashley S. Felix(Wake Forest University), Louise A. Brinton(National Cancer Institute), Olga B. Ioffe(University of Maryland, Baltimore), Michael L. Pearl(Stony Brook University), Kay J. Park(Memorial Sloan Kettering Cancer Center), Premal H. Thaker(Washington University in St. Louis), John F. Boggess(University of Kentucky), William Creasman(Medical University of South Carolina), Richard G. Moore(University of Rochester Medical Center), Joan L. Walker(Cornell University), Saketh R. Guntupalli(University of Colorado Cancer Center), Shashikant Lele(Memorial Sloan Kettering Cancer Center), David G. Mutch(Cancer Research Center), David E. Cohn(The Ohio State University), Christa Nagel(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Shamshad Ali(Gynecologic Oncology Group), Theodore M. Brasky(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Levi S. Downs(University of Toronto), Scott McMeekin(European Institute of Oncology)
Cited by 1
Related Papers
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k